Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.15 USD | +1.99% | -1.80% | +9.68% |
Financials (USD)
Sales 2024 * | 208M | Sales 2025 * | 120M | Capitalization | 1.44B |
---|---|---|---|---|---|
Net income 2024 * | 44M | Net income 2025 * | -6M | EV / Sales 2024 * | 5.06 x |
Net cash position 2024 * | 388M | Net cash position 2025 * | 637M | EV / Sales 2025 * | 6.68 x |
P/E ratio 2024 * |
34.4
x | P/E ratio 2025 * |
-30.5
x | Employees | 112 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.53% |
Latest transcript on Protagonist Therapeutics, Inc.
1 day | -4.05% | ||
1 week | -2.22% | ||
Current month | -14.76% | ||
1 month | -11.58% | ||
3 months | +1.36% | ||
6 months | +75.02% | ||
Current year | +7.54% |
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 25.15 | +1.99% | 375 548 |
24-04-25 | 24.66 | -4.05% | 606,308 |
24-04-24 | 25.7 | -4.28% | 326,485 |
24-04-23 | 26.85 | +0.90% | 339,333 |
24-04-22 | 26.61 | +3.90% | 296,277 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.54% | 1.44B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- PTGX Stock